AVDA 2015 Annual Conference Draft Schedule and Speakers Announced
AVDA is pleased to announce the draft schedule and speakers for the 2015 Annual Conference to be held at the Belmond Charleston Place Hotel in Charleston SC, April 26-28, 2015. Click here for the 2015 Annual Conference Draft Schedule.

Several changes have been made to the 2015 schedule due to the city location of this year's event. The Annual Scramble Golf Tournament has been moved to Monday afternoon to allow for travel to the Wild Dunes Links Course, approximately 30 minutes from the hotel. This Tom Fazio designed course has been consistently ranked in the top twenty-five courses in the United States since its inception in 1977. The Annual Meeting and Lunch have been moved to Tuesday afternoon and the AVDA No-Tie lounge will be held at the beautiful and historic Boone Hall Plantation on Tuesday evening.

Confirmed speakers include Steve McClatchey, Lynne Lancaster, Alan Beaulieu and Steve Gilliland. Additional information about these speakers can be found below. Details about the speaker topics and presentations will be sent out later this year and will be posted on the AVDA website. The promotional brochure for the event will be mailed to members in January 2015.

University of Innovative Distribution Registration Now Open
AVDA is one again co-sponsoring the University of Innovative Distribution (UID) March 8-11, 2015.
The newly named University of Innovative Distribution is a concentrated educational program focused on the unique needs of the wholesale distribution industry. 2015 marks the 22nd year that UID has been serving the supply chain. Known worldwide for excellence in education, UID is sponsored by the leading distribution professional associations, in cooperation with the Department of Technology Leadership and Innovation of Purdue University.
Click here for the promotional brochure
Click here to register

AVDA Board Appoints New Associate Member Director — Mick Kent, Norbrook, Inc.
The AVDA Board of Directors is pleased to announce the appointment of Mick Kent of Norbrook, Inc. to serve on the AVDA board of directors as an Associate Member director. The term of office is for three years. Mick joins Robin Mease of Merck Animal Health and Renee Hall of Merial as the third Associate Member director on the board. Mick was appointed to fill the vacancy left on the board after Bob Sztukowski of Idexx Laboratories resigned from the board.

Mick Kent is the North American Vice President in charge of food animal products for Norbrook, Inc., a pharmaceutical corporation located in Newry, Northern Ireland. Mick joined Norbrook in 2002 as the sole employee in North America. Under his leadership Norbrook, Inc. has expanded the 2002 sales results by 10 fold and the company now includes a United States headquarters in Lenexa, KS that houses sales and marketing staff, technical services, operations management and the North American regulatory department. Norbrook, Inc. is a strong supporter of animal health distribution companies in North America.

Prior to joining Norbrook, Mick worked for Syntex Animal Health for 21 years having served in a number of capacities including National Sales Manager and HR Director. After Syntex, Mick was employed by Fort Dodge Animal Health of Overland Park, KS and Vetlife, a startup company based in Lenexa, KS which was subsequently purchased by Elanco.

Mick is a graduate of the University of Missouri. He and his wife, Jill, make their home in Des Moines, Iowa and have three adult daughters and 2 granddaughters.

AVDA ITR Advisor Newsletter
AVDA is pleased to announce that AVDA has partnered with ITR Economics to provide the monthly ITR Advisor, a 4-page snapshot of the current economy, using leading indicators to tell subscribers where the economy is headed and what actions to take now. Written in a conversational tone, not heavy economic-speak, the ITR Advisor is a simple, quick, timely, and affordable way to stay informed about the state of the economy, with useful guidance and clear action points. This is another member benefit that we are providing to our members. This email newsletter will be sent to all principals and alternates at AVDA member companies.

AVDA Welcomes New Board Members
The Annual Meeting and Elections of AVDA Active Members was held on Monday, April 28, 2014 in conjunction with the AVDA Annual Conference held at the Fairmont Scottsdale Princess in Scottsdale AZ. Paula Brown of Midwest Veterinary Supply was elected to serve a two year term as President-Elect. Meryl Weinstein of Henry Schein Animal Health was elected to serve a three year term as Active Member director. She replaces Ben Coe of Henry Schein Animal Health who completed his service on the board as Immediate Past Chairman and received a watch to commemorate his seven year tenure on the board.

DEA Approves Making Tramadol a Schedule IV Controlled Substance
The Drug Enforcement Administration (DEA) recently published its decision to schedule tramadol as a Schedule IV controlled substance. The rule will become effective August 18 of this year. The DEA's action was fairly swift, having published its proposal to schedule tramadol just eight months ago. Upon conducting its eight-step analysis, the DEA found that relative to Schedule III drugs, tramadol has a low potential for abuse and limited physical dependence, and coupled with tramadol's medical legitimacy, DEA determined Schedule IV to be the most fitting for tramadol. Click here for more.

AVDA recently submitted public comments in regards to the DEA's Federal Register notice of proposed rulemaking: Schedules of Controlled Substances: Placement of Tramadol Into Schedule IV.
AVDA supports DEA's proposed rule designating Tramadol as a scheduled IV controlled substance because this action will enable distributors to operate with efficiency and consistency across the states along with requiring an increased level of due diligence and monitoring. Tramad l is an important drug in veterinary medicine and is supplied to veterinarians and animal health clinics by our distributor members. Tramadol is administered to dogs, cats and many non-domestic animals as an analgesic and as a pain reliever after surgical procedures. Click here to read the full document.

Legal Update: FTC Enforcement Actions Continue
At the September, 2013 Board meeting I advised you of recent activity of the Federal Trade Commission pertaining to the exchange of sensitive business information by and between competitors (Federal Trade Commission v. Bosley, No. 121-0184). While the information exchange was clearly inadvisable, the Commission's position was not based upon any allegations of harm to competition. Rather, the Commission used its authority under Section 5 of the FTC Act to find the Respondent violated the Act solely by exchanging the information and presuming such an exchange could lead to an adverse impact on competition.

The FTC continues to scrutinize the activities of competitors and trade associations. The Commission recently published proposed consent orders in two cases involving trade associations which are discussed below. Click here to read the full update.